NEW YORK – October 29, 2026 -- The Huntington's Disease Foundation (HDF) has awarded $2 million across two 2026 Transformative Research Awards (TRAs), giving $1 million each to teams targeting the toxic huntingtin protein behind Huntington's disease (HD).

HDF typically funds one TRA a year. CEO Meghan Donaldson said the "extraordinary potential" of both proposals warranted funding each. The foundation attributes the expanded round to new major donors.